Pakistan’s Drug Regulatory Authority approves the AstraZeneca coronavirus vaccine to be used in an emergency.
- Oxford-AstraZeneca covid-19 vaccine has an efficacy of 70%
- Oxford-AstraZeneca was first approved by the British govt
- Pakistan to roll out AstraZeneca vaccines from March
Pakistan has approved the use of the AstraZeneca vaccine for COVID-19 as the country struggles with the second wave of disease.
With infections soaring across Pakistan, more than 34,000 cases have been reported in the first two weeks of January, and the coronavirus has killed an average of 48.8 people every day as the hospital intensive care unit is nearly approaching over the past 15 days.
In an interview with Prime Minister Imran Khan’s Special Health Adviser, Dr. Faisal Sultan confirmed that the DRAP approved the emergency use of the AstraZeneca coronavirus vaccine across the country.
Head of the NCOC, Asad Umar, told that the covid-19 vaccine will be introduced by March. In the first stage, the vaccine will be given to healthcare workers and those aged 65 and over.
When the human body is vaccinated, it stimulates the immune system to make antibodies and train it to attack any virus infection caused by covid-19. Internal data showed that the effectiveness of the corona vaccine in preventing symptomatic infections was 70%.
The Oxford-AstraZeneca Covid-19 vaccine is more suitable for developing countries as it can be stored for up to six months in a normal fridge, making it much easier to entertain and distribute. It’s also cheaper to produce. This covid-19 vaccine was first approved for use in crisis by the British government.
Being Helper is not responsible for content on external links.